文献速递传染病防控与疫情报告卫生政策与健康促进

卡芬太尼疫情——佛罗里达州,2016-2017年

Carfentanil Outbreak - Florida, 2016-2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2020-02-07

2016至2017年佛罗里达州发生卡芬太尼相关致命过量疫情,萨拉索塔地区(萨拉索塔、马纳提、德索托三县)为疫情中心,占全州1,181例卡芬太尼死亡中的19.0%,且死亡高峰早于全州更大疫情。2017年8至12月仅报告1例卡芬太尼死亡(2016年同期为73例),似标志该地区疫情结束。

要点

  • 萨拉索塔地区占全州1,181例卡芬太尼死亡中的19.0%,疫情高峰早于全州。
  • 2017年8至12月仅报告1例卡芬太尼死亡,2016年同期为73例。
  • 卡芬太尼据报效力约为吗啡的10,000倍、芬太尼的100倍,美国无批准的人体治疗用途。

核心结论

  • 快速、密集的致命过量疫情威胁凸显了加速报告、可靠数据共享系统和新型主动监测的必要性,以支持公共卫生与安全机构的针对性预防和应对工作。

研究设计与样本

  • 本报告描述了2016年1月至2017年12月佛罗里达州萨拉索塔地区(萨拉索塔、马纳提、德索托三县法医辖区)与佛罗里达州其余地区(即除萨拉索塔地区外的所有佛罗里达州县)卡芬太尼相关致命过量(卡芬太尼死亡)的毒理学特征、社会人口学信息和地理分布。

主要发现

  • 萨拉索塔地区占此期间全州1,181例卡芬太尼死亡中的19.0%,且卡芬太尼死亡高峰早于佛罗里达州更大疫情。
  • 2017年8至12月仅报告1例卡芬太尼死亡,而2016年同期报告73例死亡,似标志该地区疫情结束。

关键数值与推荐

  • 卡芬太尼据报效力约为吗啡的10,000倍、芬太尼的100倍。
  • 卡芬太尼用于兽医领域快速制动大型动物,美国无批准的人体治疗用途。
  • 卡芬太尼每剂街头价格可能低于海洛因。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increased prevalence of illicitly manufactured fentanyl and fentanyl analogs has contributed substantially to overdose deaths in the United States (1-3). On October 26, 2015, CDC issued a Health Advisory regarding rapid increases in deaths involving fentanyl. This CDC Health Advisory has been updated twice to address increases in fentanyl and fentanyl analog overdoses and their co-occurrence with nonopioids (4). Deaths involving carfentanil, an analog reportedly 10,000 times more potent than morphine and 100 times more potent than fentanyl, were first reported in Florida, Michigan, and Ohio in 2016 and described in an August 2016 CDC Health Advisory (1,5). Carfentanil is used to rapidly immobilize large animals in veterinary medicine and has no U.S. approved therapeutic use in humans. Carfentanil's street price per dose is likely lower than that of heroin. During 2016 and 2017, an outbreak of carfentanil-involved fatal overdoses in Florida emerged, and the Medical Examiner jurisdiction serving Sarasota, Manatee, and DeSoto counties (the Sarasota area) was the outbreak epicenter. This report describes toxicology profiles, sociodemographic information, and geographic distributions of carfentanil-involved fatal overdoses (carfentanil deaths) in the Sarasota area compared with those in the rest of Florida (i.e., all Florida counties excluding Sarasota area) from January 2016 to December 2017. The Sarasota area accounted for 19.0% of 1,181 statewide carfentanil deaths that occurred during this time and experienced a peak in carfentanil deaths preceding the larger Florida outbreak. The report of a single carfentanil death from August to December 2017 (compared with 73 reported deaths during the same period in 2016) appeared to mark the end of the outbreak in the area. The threat of such rapid, intense fatal overdose outbreaks highlights the need for accelerated reporting, reliable data sharing systems, and novel proactive surveillance to support targeted prevention and response efforts by public health and safety organizations (6).

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Delcher C, Wang Y, Vega RS, et al. Carfentanil Outbreak - Florida, 2016-2017. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32027630. doi:10.15585/mmwr.mm6905a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。